Rosanna Tavella

Dr. Rosanna Tavella

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2015 in Circulation
Verified
Journal Article
Open access
PDF file
SPSivabaskari Pasupathy
Sivabaskari Pasupathy
TATracy Air
Tracy Air
RDRachel P. Dreyer
Rachel P. Dreyer
RTRosanna Tavella
Rosanna Tavella
JBJohn Beltrame
John Beltrame
Background—Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a puzzling clinical entity with no previous evaluation of the literature. This systematic review aims to (1) quantify the prevalence, risk factors, and 12-month prognosis in patients with MINOCA, and (2) evaluate potential pathophysiological mechanisms underlying this disorder. Methods and Results—Quantitative assessment of 28 publications using a meta-analytic approach evaluated the prevalence, clinical features, and prognosis of MINOCA. The prevalence of MINOCA was 6% [95% confidence interval, 5%–7%] with a median patient age of 55 years (95% confidence interval, 51–59 years) and 40% women. However, in comparison with those with myocardial infarction associated with obstructive coronary artery disease, the patients with MINOCA were more likely to be younger and female but less likely to have hyperlipidemia, although other cardiovascular risk factors were similar. All-cause mortality at 12 months was lower in MINOCA (4.7%; 95% confidence interval, 2.6%–6.9%) compared with myocardial infarction associated with obstructive coronary artery disease (6.7%, 95% confidence interval, 4.3%–9.0%). Qualitative assessment of 46 publications evaluating the underlying pathophysiology responsible for MINOCA revealed the presence of a typical myocardial infarct on cardiac magnetic resonance imaging in only 24% of patients, with myocarditis occurring in 33% and no significant abnormality in 26%. Coronary artery spasm was inducible in 27% of MINOCA patients, and thrombophilia disorders were detected in 14%. Conclusions—MINOCA should be considered as a working diagnosis with multiple potential causes that require evaluation so that directed therapies may improve its guarded prognosis.

5 August 2013 in Medical Journal of Australia
Verified
Journal Article
Closed access
DCDerek P Chew
Derek P Chew
JFJohn French
John French
TBTom G Briffa
Tom G Briffa
CHChristopher J Hammett
Christopher J Hammett
CEChristopher J Ellis
Christopher J Ellis
DBDavid B Brieger
David B Brieger
Objectives: To characterise management of suspected acute coronary syndrome (ACS) in Australia and New Zealand, and to assess the application of recommended therapies according to published guidelines.Design, setting and patients: All patients hospitalised with suspected or confirmed ACS between 14 and 27 May 2012 were enrolled from participating sites in Australia and New Zealand, which were identified through public records and health networks. Descriptive and ...

12 September 2009 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
JBJohn Beltrame
John Beltrame
AWAndrew J. Weekes
Andrew J. Weekes
CMClaire Morgan
Claire Morgan
RTRosanna Tavella
Rosanna Tavella
JSJohn A. Spertus
John A. Spertus
The major clinical manifestations of coronary artery disease (CAD) include acute coronary syndromes (ACS) and chronic stable angina. Although ACS typically result in hospital admission and are therefore readily identified through administrative data or national registries,1-3 the more prevalent condition of chronic stable angina is predominantly managed in the outpatient setting where data are less readily available. Those that are available are often derived from hospital specialist clinics4 or follow-up of hospital-based ACS registries5,6 and may not reflect the status of patients' angina in primary care practices.

21 June 2019 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
RDRachel P Dreyer
Rachel P Dreyer
RTRosanna Tavella
Rosanna Tavella
JCJeptha P Curtis
Jeptha P Curtis
YWYongfei Wang
Yongfei Wang
SPSivabaskari Pauspathy
Sivabaskari Pauspathy
JBJohn Beltrame
John Beltrame
The prognosis of patients with MINOCA (myocardial infarction with non-obstructive coronary arteries) is poorly understood. We examined major adverse cardiac events (MACE) defined as all-cause mortality, re-hospitalization for acute myocardial infarction (AMI), heart failure (HF), or stroke 12-months post-AMI in patients with MINOCA versus AMI patients with obstructive coronary artery disease (MICAD). Multicentre, observational cohort study of patients with AMI (≥65 years) from the National Cardiovascular Data Registry CathPCI Registry (July 2009–December 2013) who underwent coronary angiography with linkage to the Centers for Medicare and Medicaid (CMS) claims data. Patients were classified as MICAD or MINOCA by the presence or absence of an epicardial vessel with ≥50% stenosis. The primary endpoint was MACE at 12 months, and secondary endpoints included the components of MACE over 12 months. Among 286 780 AMI admissions (276 522 unique patients), 16 849 (5.9%) had MINOCA. The 12-month rates of MACE (18.7% vs. 27.6%), mortality (12.3% vs. 16.7%), and re-hospitalization for AMI (1.3% vs. 6.1%) and HF (5.9% vs. 9.3%) were significantly lower for MINOCA vs. MICAD patients (P < 0.001), but was similar between MINOCA and MICAD patients for re-hospitalization for stroke (1.6% vs. 1.4%, P = 0.128). Following risk-adjustment, MINOCA patients had a 43% lower risk of MACE over 12 months (hazard ratio = 0.57, 95% confidence interval 0.55–0.59), in comparison to MICAD patients. This pattern was similar for adjusted risks of the MACE components. This study confirms an unfavourable prognosis in elderly patients with MINOCA undergoing coronary angiography, with one in five patients with MINOCA suffering a major adverse event over 12 months.

1 November 2021 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Open access
PDF file
SPSivabaskari Pasupathy
Sivabaskari Pasupathy
BLBertil Lindahl
Bertil Lindahl
PLPeter Litwin
Peter Litwin
RTRosanna Tavella
Rosanna Tavella
MWMichael J.A. Williams
Michael J.A. Williams
JBJohn Beltrame
John Beltrame
Background: Suspected myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) occurs in ≈5% to 10% of patients with MI referred for coronary angiography. The prognosis of these patients may differ to those with MI and obstructive coronary artery disease (MI-CAD) and those without a MI (patients without known history of MI [No-MI]). The primary objective of this study is to evaluate the 12-month all-cause mortality of patients with MINOCA. Methods: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, the terms “MI,” “nonobstructive,” “angiography,” and “prognosis” were searched in PubMed and Embase databases from inception to December 2018, including original, English language MINOCA studies with >100 consecutive patients. Publications with a heterogeneous cohort, unreported coronary stenosis, or exclusively focusing on MINOCA-mimicking conditions, were excluded. Unpublished data were obtained from the MINOCA Global Collaboration. Data were pooled and analyzed using Paule-Mandel, Hartung, Knapp, Sidik & Jonkman, or restricted maximum-likelihood random-effects meta-analysis methodology. Heterogeneity was assessed using Cochran’s Q and I 2 statistics. The primary outcome was 12-month all-cause mortality in patients with MINOCA, with secondary comparisons to MI-CAD and No-MI. Results: The 23 eligible studies yielded 55 369 suspected MINOCA, 485 382 MI-CAD, and 33 074 No-MI. Pooled meta-analysis of 14 MINOCA studies accounting for 30 733 patients revealed an unadjusted 12-month all-cause mortality rate of 3.4% (95% CI, 2.6%–4.2%) and reinfarction (n=27 605; 10 studies) in 2.6% (95% CI, 1.7%–3.5%). MINOCA had a lower 12-month all-cause mortality than those with MI-CAD (3.3% [95% CI, 2.5%–4.1%] versus 5.6% [95% CI, 4.1%–7.0%]; odds ratio, 0.60 [95% CI, 0.52–0.70], P <0.001). In contrast, there was a statistically nonsignificant trend towards increased 12-month all-cause mortality in patients with MINOCA (2.6% [95% CI, 0%–5.9%]) compared with No-MI (0.7% [95% CI, 0.1%–1.3%]; odds ratio, 3.71 [95% CI, 0.58–23.61], P =0.09). Conclusions: In the largest contemporary MINOCA meta-analysis to date, patients with suspected MINOCA had a favorable prognosis compared with MI-CAD, but statistically nonsignificant trend toward worse outcomes compared to those with No-MI. Registration: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD42020145356.

1 October 2013 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
RDRachel P. Dreyer
Rachel P. Dreyer
JBJohn F. Beltrame
John F. Beltrame
RTRosanna Tavella
Rosanna Tavella
TATracy Air
Tracy Air
BHBernadette Hoffmann
Bernadette Hoffmann
CZChristopher Zeitz
Christopher Zeitz